Professor J Louise Jones

J Louise Jones

Professor of Breast Pathology

Barts Cancer Institute
www.bci.qmul.ac.uk/staff/professor-louise-jones/

Research

Breast Cancer, DCIS, Tumour microenvironment

Cancer Models

Interests

Professor of Breast Pathology, Barts Health NHS Trust and Head of Breast Research Group in Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, with research focus on the role of the microenvironment in mediating progression of DCIS to invasive breast cancer.

Co-PI of the National Breast Cancer Now Biobank which includes the Primary Breast Cell Bank, isolating cell populations from tissues for the research community – established in 2010, now delivering samples internationally to support research.

Co-Lead and Chief Scientific Officer of PharosAI – generating multi-modal datasets on primary cancer sample cohorts to translate artificial intelligence in cancer diagnostics into the clinical setting.

Publications

solid heart iconPublications of specific relevance to Predictive in vitro Models

2026

Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer
Bernstein AJ, Keeman R, Hurson A, Blows FM, Bolla MK, Miller JL, Milne RL, Horlings H et al.
Iscience, Elsevier vol. 29 (2) 
20-01-2026

2025

Abstract P2-06-15: DCIS-associated myoepithelial cells drive transcriptional alterations in macrophages through up-regulation of integrin αvβ6
Allen M, Roozitalab MR, Murtough S, Maniati E, Jones JL
Clinical Cancer Research, American Association For Cancer Research (Aacr) vol. 31 (12_Supplement) 
13-06-2025
Advancing breast, lung and prostate cancer research with federated learning. A systematic review
Ankolekar A, Boie S, Abdollahyan M, Gadaleta E, Hasheminasab SA, Yang G, Beauville C, Dikaios N et al.
Npj Digital Medicine, Springer Nature vol. 8 (1) 
27-05-2025
The clinical and molecular landscape of breast cancer in women of African and South Asian ancestry
Thorn GJ, Gadaleta E, Dayem Ullah AZM, James LGE, Abdollahyan M, Barrow-McGee R, Jones LJ, Chelala C
Nature Communications, Springer Nature vol. 16 (1) 
20-05-2025
Benign/Cancer Diagnostics Based on X-Ray Diffraction: Comparison of Data Analytics Approaches
Alekseev A, Shcherbakov V, Avdieiev O, Denisov SA, Kubytskyi V, Blinchevsky B, Murokh S, Ajeer A et al.
Cancers, Mdpi vol. 17 (10) 
14-05-2025
Clinical utility of ‘Shaken’ biopsies for whole-genome sequencing
Nelan R, Mijuskovic M, Hughes M, Becq J, Kingsbury Z, Tsogka E, He M, Vucenovic D et al.
Journal of Clinical Pathology, Bmj vol. 79 (1), 4-11.  
03-03-2025
Metastasis to and from the breast: a guide to differential diagnosis and ancillary testing
Sidlauskas K, Elliott P, Makhija P, Jones JL
Diagnostic Histopathology, Elsevier vol. 31 (3), 162-173.  
01-03-2025
The relationship between the gastric cancer microbiome and clinicopathological factors: a metagenomic investigation from the 100,000 genomes project and The Cancer Genome Atlas
Booth ME, Wood HM, Travis MA, Quirke P, Grabsch HI
Gastric Cancer, Springer Nature vol. 28 (3), 358-371.  
17-02-2025
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease
Elhassan EAE, Collins KE, Heneghan S, Gilbert E, Yang H, Senum SR, Schauer RS, Elbarougy DE et al.
Journal of Nephrology, Oxford University Press (Oup) vol. 38 (5), 1457-1467.  
30-01-2025

2024

Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate
Hirani P, McDermott J, Rajeeve V, Cutillas PR, Jones JL, Pennington DJ, Wight TN, Santamaria S et al.
Cancer Research Communications, American Association For Cancer Research (Aacr) vol. 4 (4), 970-985.  
03-04-2024
A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast
Reed AD, Pensa S, Steif A, Stenning J, Kunz DJ, Porter LJ, Hua K, He P et al.
Nature Genetics, Springer Nature vol. 56 (4), 652-662.  
28-03-2024

2023

The Future of Precision Oncology
Rulten SL, Grose RP, Gatz SA, Jones JL, Cameron AJM
International Journal of Molecular Sciences, Mdpi vol. 24 (16) 
09-08-2023
Recent Advances in Pathology: the 2023 Annual Review Issue of The Journal of Pathology
Jones JL, Poulsom R, Coates PJ
The Journal of Pathology, Wiley vol. 260 (5), 495-497.  
01-08-2023
Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large‐scale studies
Verghese G, Li M, Liu F, Lohan A, Kurian NC, Meena S, Gazinska P, Shah A et al.
The Journal of Pathology, Wiley vol. 260 (4), 376-389.  
25-05-2023
TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression
Gibson SV, Tomas Bort E, Rodríguez-Fernández L, Allen MD, Gomm JJ, Goulding I, auf dem Keller U, Agnoletto A et al.
Npj Breast Cancer, Springer Nature vol. 9 (1) 
02-03-2023
Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study
Zhang C, Xu L, Ma Y, Huang Y, Zhou L, Le H, Chen Z
Journal of Thoracic Disease, Ame Publishing Company 
01-03-2023
Everybody needs good neighbours: the progressive DCIS microenvironment
Gibson SV, Roozitalab RM, Allen MD, Jones JL, Carter EP, Grose RP
Trends in Cancer, Elsevier vol. 9 (4), 326-338.  
02-02-2023

2022

Intra-operative assessment of cancer with x-ray phase contrast computed tomography
Partridge T, Massimi L, Wolfson P, Jiang J, Astolfo A, Suaris T, Havariyoun G, Savvidis S et al.
Developments in X-Ray Tomography XIV. 
14-10-2022
Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion
Hayward M-K, Allen MD, Gomm JJ, Goulding I, Thompson CL, Knight MM, Marshall JF, Jones JL
Npj Breast Cancer, Springer Nature vol. 8 (1) 
20-09-2022
Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex Immunofluorescence
Badr NM, McMurray JL, Danial I, Hayward S, Asaad NY, El-Wahed MMA, Abdou AG, El-Dien MMS et al.
Pathobiology, Karger Publishers vol. 90 (1), 31-43.  
15-06-2022
A biobank perspective on use of tissue samples donated by trial participants
Speirs V, Cox A, Chelala C, James JA, Adams RA, Jones JL
The Lancet Oncology, Elsevier vol. 23 (5) 
01-05-2022

2021

Exploring the potential of cycloidal computed tomography for advancing intraoperative specimen imaging
Roche i Morgo O, Massimi L, Suaris T, Endrizzi M, Munro P, Savvidis S, Havariyoun G, Hawker PMS et al.
Developments in X-Ray Tomography XIII. 
09-09-2021
Detection of involved margins in breast specimens with X-ray phase-contrast computed tomography
Massimi L, Suaris T, Hagen CK, Endrizzi M, Munro PRT, Havariyoun G, Hawker PMS, Smit B et al.
Scientific Reports, Springer Nature vol. 11 (1) 
11-02-2021

2020

Subcellular mRNA Localization Regulates Ribosome Biogenesis in Migrating Cells
Dermit M, Dodel M, Lee FCY, Azman MS, Schwenzer H, Jones JL, Blagden SP, Ule J et al.
Developmental Cell, Elsevier vol. 55 (3), 298-313.e10.  
01-11-2020
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells
Wong P-P, Muñoz-Félix JM, Hijazi M, Kim H, Robinson SD, De Luxán-Delgado B, Rodríguez-Hernández I, Maiques O et al.
Cell, Elsevier vol. 181 (6), 1346-1363.e21.  
29-05-2020

2019

A novel use of random priming-based single-strand library preparation for whole genome sequencing of formalin-fixed paraffin-embedded tissue samples
Saunderson EA, Baker A-M, Williams M, Curtius K, Jones JL, Graham TA, Ficz G
Nar Genomics and Bioinformatics, Oxford University Press (Oup) vol. 2 (1) 
16-12-2019
A compact system for intraoperative specimen imaging based on edge illumination x-ray phase contrast
Havariyoun G, Vittoria FA, Hagen CK, Basta D, Kallon GK, Endrizzi M, Massimi L, Munro P et al.
Physics in Medicine and Biology, Iop Publishing vol. 64 (23) 
26-11-2019
Breast implant‐associated anaplastic large cell lymphoma (BIA‐ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management
Jones JL, Hanby AM, Wells C, Calaminici M, Johnson L, Turton P, Deb R, Provenzano E et al.
Histopathology, Wiley vol. 75 (6), 787-796.  
06-10-2019
CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom
Macklin PS, Pillay N, Lee JL, Pitman H, Scott S, Wang J, Craig C, Jones JL et al.
British Journal of Cancer, Springer Nature vol. 121 (9), 738-743.  
02-10-2019
Survey of UK histopathology consultants’ attitudes towards academic and molecular pathology
Brockmoeller S, Young C, Lee J, Arends MJ, Wilkins BS, Thomas GJ, Oien KA, Jones L et al.
 
25-03-2019
Laboratory-based x-ray phase contrast CT technology for clinical intra-operative specimen imaging
Massimi L, Hagen CK, Endrizzi M, Munro PRT, Havariyoun G, Hawker PMS, Smit B, Astolfo A et al.
Medical Imaging 2019: Physics of Medical Imaging. 
01-03-2019

2018

Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
Coulson‐Gilmer C, Humphries MP, Rajan SS, Droop A, Jackson S, Condon A, Cserni G, Jordan LB et al.
The Journal of Pathology Clinical Research, Wiley vol. 4 (4), 241-249.  
23-08-2018
Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers
Pearce OMT, Delaine-Smith RM, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D et al.
Cancer Discovery, American Association For Cancer Research (Aacr) vol. 8 (3) 
01-03-2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer
Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker A-M, Kapitonova E, Bakhouche BA, Tanner Y et al.
Cell Reports, Elsevier vol. 22 (9), 2469-2481.  
01-02-2018
Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities
Pollard J, Burns PA, Hughes TA, Ho-Yen C, Jones JL, Mukherjee G, Omoniyi-Esan GO, Titloye NA et al.
Pathobiology, Karger Publishers vol. 85 (4), 220-226.  
01-01-2018

2017

Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
Saunderson EA, Stepper P, Gomm JJ, Hoa L, Morgan A, Allen MD, Jones JL, Gribben JG et al.
Nature Communications, Springer Nature vol. 8 (1) 
13-11-2017
Time for change: a new training programme for morpho-molecular pathologists?
Moore DA, Young CA, Morris HT, Oien KA, Lee JL, Jones JL, Salto-Tellez M
Journal of Clinical Pathology, Bmj vol. 71 (4) 
07-11-2017
Morphomolecular pathology: setting the framework for a new generation of pathologists
Jones JL, Oien KA, Lee JL, Salto-Tellez M
British Journal of Cancer, Springer Nature vol. 117 (11), 1581-1582.  
01-11-2017
The growth of molecular diagnostics: Stratified Medicine Programme, the 100,000 Genomes Project and the future
Nelan RL, Hayward M-K, Jones JL
Diagnostic Histopathology, Elsevier vol. 23 (10), 458-467.  
01-10-2017
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer
Humphries MP, Rajan SS, Droop A, Suleman CAB, Carbone C, Nilsson C, Honarpisheh H, Cserni G et al.
Clinical Cancer Research, American Association For Cancer Research (Aacr) vol. 23 (10), 2575-2583.  
14-05-2017
A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer
Carter EP, Gopsill JA, Gomm JJ, Jones JL, Grose RP
Breast Cancer Research, Springer Nature vol. 19 (1) 
21-04-2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
Humphries MP, Sundara Rajan S, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL et al.
Scientific Reports, Springer Nature vol. 7 (1) 
28-03-2017
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function
Sarper M, Allen MD, Gomm J, Haywood L, Decock J, Thirkettle S, Ustaoglu A, Sarker S-J et al.
Breast Cancer Research, Springer Nature vol. 19 (1) 
23-03-2017
Abstract P4-15-04: Molecular mediators of mammographic density
Ironside A, Hawkesford K, Gomm J, Haywood L, Goulding I, Wang J, Lamaziere A, Poirot M et al.
 
15-02-2017

2016

Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer
Patel H, Abduljabbar R, Lai C-F, Periyasamy M, Harrod A, Gemma C, Steel JH, Patel N et al.
Clinical Cancer Research, American Association For Cancer Research (Aacr) vol. 22 (23), 5929-5938.  
30-11-2016
Investigating the Functional Significance of Aberrant alpha v beta 6 and Fibronectin Expression in Myoepithelial Cells: Role in the Progression of DCIS?
Hayward M, Allen MD, Dreger S, Marshall JF, Jones JL
Nottingham Pathology 2016 28 Jun 2016 - 1 Jul 2016. 
01-10-2016
UK Breast Cancer Research Symposium 2016: Submitted Abstracts
 
01-08-2016
SEARCHBreast: a new online resource to make surplus material from in vivo models of breast cancer visible and accessible to researchers
Morrissey B, Blyth K, Carter P, Chelala C, Jones L, Holen I, Speirs V
Breast Cancer Research, Springer Nature vol. 18 (1) 
31-05-2016
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes
Purrington KS, Visscher DW, Wang C, Yannoukakos D, Hamann U, Nevanlinna H, Cox A, Giles GG et al.
Breast Cancer Research and Treatment, Springer Nature vol. 157 (1), 117-131.  
15-04-2016
The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis
Clarke CJ, Berg TJ, Birch J, Ennis D, Mitchell L, Cloix C, Campbell A, Sumpton D et al.
Current Biology, Elsevier vol. 26 (6), 755-765.  
01-03-2016
Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?
Winters ZE, Horsnell J, Schmid P, Jones JL, Shaaban A, Maxwell AJ, Williams N, Esserman L et al.
The Breast, Elsevier vol. 26, 149-150.  
03-02-2016
Stromal characteristics may hold the key to mammographic density: the evidence to date
Ironside AJ, Jones JL
Oncotarget, Impact Journals vol. 7 (21), 31550-31562.  
13-01-2016

2015

A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial
Davies MJ, Gray LJ, Troughton J, Gray A, Tuomilehto J, Farooqi A, Khunti K, Yates T et al.
Preventive Medicine, Elsevier vol. 84, 48-56.  
29-12-2015
Genetic testing in a cohort of young patients with HER2-amplified breast cancer
Eccles DM, Li N, Handwerker R, Maishman T, Copson ER, Durcan LT, Gerty SM, Jones L et al.
Annals of Oncology, Elsevier vol. 27 (3), 467-473.  
17-12-2015
Promoting early presentation of breast cancer in women over 70 years old in general practice
Campbell J, Pyer M, Rogers S, Jones J, Ramirez AJ, Forbes LJL
Journal of Public Health, Oxford University Press (Oup) vol. 38 (3), 591-598.  
10-09-2015
Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.
Downey CL, Simpkins SA, Holliday DL, Jones JL, Jordan LB, Kulka J, Hanby AM, Speirs V
Br J Cancer vol. 112 (11), 1833-1834.  
26-05-2015
Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained from a female-to-male transgender patient
Millican-Slater R, Good R, Nash C, Heads JA, Pollock S, Chalkley R, Gomm J, Jones JL et al.
Cell and Tissue Banking vol. 16 (1), 27-34.  
01-03-2015
The clinical and functional significance of c-Met in breast cancer: a review
Ho-Yen CM, Jones JL, Kermorgant S
Breast Cancer Research, Springer Nature vol. 17 (1) 
01-01-2015

2014

αvβ6 Expression in myoepithelial cells: a novel marker for predicting DCIS progression with therapeutic potential.
Allen MD, Marshall JF, Jones JL
Cancer Res vol. 74 (21), 5942-5947.  
01-11-2014
Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.
Wong P-P, Yeoh CC, Ahmad AS, Chelala C, Gillett C, Speirs V, Jones JL, Hurst HC
Oncogene vol. 33 (37), 4579-4588.  
11-09-2014
Therapeutic targeting of integrin αvβ6 in breast cancer.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.
J Natl Cancer Inst vol. 106 (8) 
01-08-2014
Rigidity sensing and adaptation through regulation of integrin types.
Elosegui-Artola A, Bazellières E, Allen MD, Andreu I, Oria R, Sunyer R, Gomm JJ, Marshall JF et al.
Nat Mater vol. 13 (6), 631-637.  
01-06-2014
Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained from a female-to-male transgender patient
Millican-Slater R, Good R, Nash C, Heads JA, Pollock S, Chalkley R, Gomm J, Jones JL et al.
Cell and Tissue Banking, Springer Nature vol. 16 (1), 27-34.  
09-04-2014
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer.
Downey CL, Simpkins SA, White J, Holliday DL, Jones JL, Jordan LB, Kulka J, Pollock S et al.
Br J Cancer vol. 110 (7), 1744-1747.  
02-04-2014
Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer.
Alexopoulou AN, Ho-Yen CM, Papalazarou V, Elia G, Jones JL, Hodivala-Dilke K
Bmc Cancer vol. 14 
02-04-2014
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
Allen MD, Thomas GJ, Clark S, Dawoud MM, Vallath S, Payne SJ, Gomm JJ, Dreger SA et al.
Clin Cancer Res vol. 20 (2), 344-357.  
15-01-2014
Hard X-ray dark-field imaging with incoherent sample illumination
Endrizzi M, Diemoz PC, Millard TP, Jones JL, Speller RD, Robinson IK, Olivo A
Applied Physics Letters vol. 104 (2) 
01-01-2014
The Breast Cancer Campaign Tissue Bank: Generating new biomaterials to accelerate breast cancer research
Speirs V, Chelala C, Coates R, Jones JL, Matharoo-Ball B, Quinlan P
 
01-01-2014
Manipulation of macrophage Fc gamma receptors to improve antibody immunotherapy of HER2+breast cancer
Laversin SA, Krishnan J, Schapira A, Dou L, Ashton-Key M, Jones JL, Allen MD, Glennie MJ et al.
Immunology vol. 143, 128-129.  
01-01-2014

2013

Abstract P4-15-01: Integrin avb6 is a therapeutic target for high-risk breast cancer and enhances trastuzumab efficacy
Moore K, Thomas G, Duffy S, Warwick J, Gabe R, Chou P, Ellis I, Green A et al.
Cancer Research, American Association For Cancer Research (Aacr) vol. 73 (24_Supplement) 
15-12-2013
C-Met in invasive breast cancer: is there a relationship with the basal-like subtype?
Ho-Yen CM, Green AR, Rakha EA, Brentnall AR, Ellis IO, Kermorgant S, Jones JL
Cancer, Wiley vol. 120 (2), 163-171.  
21-10-2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, Carassiti D, Reynolds R et al.
Brain, Oxford University Press (Oup) vol. 136 (9), 2888-2903.  
17-07-2013
GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness.
Gaynor K, Grigorieva I, Allen MD
Hormones and Cancer, Springer-Verlag vol. Volume 4 (3), 123-139.  
01-06-2013
Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'.
Ho-Yen C, Bowen RL, Kermorgant S, Jones JL
Br J Cancer vol. 108 (10), 2195-2196.  
28-05-2013
Low-dose phase contrast mammography with conventional x-ray sources
Olivo A, Gkoumas S, Endrizzi M, Hagen CK, Szafraniec MB, Diemoz PC, Munro PRT, Ignatyev K et al.
Medical Physics vol. 40 (9) 
01-01-2013
Differential Expression of MicroRNAs in Breast Cancers From Four Different Ethnicities
Pollard JA, Burns PA, Hughes TA, Mukherjee G, Jones JL, Ho-Yen C, Esan GOO, Titloye NA et al.
 
01-01-2013
Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.
Robbez-Masson LJ, Bödör C, Jones JL, Hurst HC, Fitzgibbon J, Hart IR, Grose RP
Plos One vol. 8 (11) 
01-01-2013
Rigidity sensing and adaptation through regulation of integrin populations
Elosegui-Artola A, Bazellieres E, Allen MD, Andreu I, Marshall JF, Jones JL, Trepat X, Roca-Cusachs P
Molecular Biology of The Cell vol. 24 
01-01-2013

2012

Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer.
Verma R, Bowen RL, Slater SE, Mihaimeed F, Jones JL
Br Med Bull vol. 103 (1), 129-145.  
01-09-2012
Characterization of basal-like breast cancer: an update
Ho-Yen C, Bowen RL, Jones JL
Diagnostic Histopathology, Elsevier vol. 18 (3), 104-111.  
01-03-2012
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
Hill-Cawthorne GA, Button T, Tuohy O, Jones JL, May K, Somerfield J, Green A, Giovannoni G et al.
Journal of Neurology Neurosurgery and Psychiatry vol. 83 (3), 298-304.  
01-01-2012
Breast Cancer - The Beginning
Jones JL
 
01-01-2012
Loss of MMP-8 Expression Contributes to Altered Myoepithelial Cell Function in DCIS
Sarper M, Allen M, Decock J, Marshall JF, Edwards DR, Jones JL
 
01-01-2012
MYOEPITHELIAL CONTROL OF THE INFLAMMATORY MICROENVIRONMENT PROMOTES TRANSITION OF DCIS TO INVASIVE DISEASE
Ahmed KO, Allen M, Gomm J, Marshall J, Jones JL
 
01-01-2012
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study
Shaw EC, Hanby AM, Wheeler K, Shaaban AM, Poller D, Barton S, Treanor D, Fulford L et al.
Journal of Clinical Pathology vol. 65 (5), 403-408.  
01-01-2012
Up-regulation of αvβ6 integrin and fibronectin EDA in myoepithelial cells contribute to the angiogenic switch in pre-invasive breast cancer
Dreger SA, Payne SJ, Dawoud M, Robinson SD, Marshall JF, Hodivala-Dilke KM, Allen MD, Jones JL
 
01-01-2012
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
Shaaban AM, Ball GR, Brannan RA, Cserni G, Di Benedetto A, Dent J, Fulford L, Honarpisheh H et al.
Breast Cancer Research and Treatment vol. 133 (3), 949-958.  
01-01-2012
Gene expression analysis in human breast cancer associated blood vessels.
Jones DT, Lechertier T, Mitter R, Herbert JMJ, Bicknell R, Jones JL, Li J-L, Buffa F et al.
Plos One vol. 7 (10) 
01-01-2012

2011

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM
J Med Genet vol. 48 (8), 520-522.  
01-08-2011
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion.
Allen MD, Vaziri R, Green M, Chelala C, Brentnall AR, Dreger S, Vallath S, Nitch-Smith H et al.
J Pathol vol. 223 (5), 646-658.  
01-04-2011
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL
Br J Cancer vol. 104 (1), 120-127.  
04-01-2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M et al.
Breast Cancer Research vol. 13 (6) 
01-01-2011
Jekyll and Hyde: the role of the microenvironment on the progression of cancer
Allen M, Jones JL
J Pathol vol. 223 (2), 162-176.  
01-01-2011

2010

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
Wilson JRF, Bateman AC, Hanson H, An Q, Evans G, Rahman N, Jones JL, Eccles DM
J Med Genet vol. 47 (11), 771-774.  
01-11-2010
Characterization of breast tissue using energy-dispersive X-ray diffraction computed tomography.
Pani S, Cook EJ, Horrocks JA, Jones JL, Speller RD
Appl Radiat Isot vol. 68 (10), 1980-1987.  
01-10-2010
Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.
da Silva RG, Tavora B, Robinson SD, Reynolds LE, Szekeres C, Lamar J, Batista S, Kostourou V et al.
Am J Pathol vol. 177 (3), 1534-1548.  
01-09-2010
Breast cancer dormancy can be maintained by small numbers of micrometastases.
Willis L, Alarcón T, Elia G, Jones JL, Wright NA, Tomlinson IPM, Graham TA, Page KM
Cancer Res vol. 70 (11), 4310-4317.  
01-06-2010
Tetraspanin CD151 Regulates Growth of Mammary Epithelial Cells in Three-Dimensional Extracellular Matrix: Implication for Mammary Ductal Carcinoma In situ
Novitskaya V, Romanska H, Dawoud M, Jones JL, Berditchevski F
Cancer Res vol. 70 (11), 4698-4708.  
01-06-2010
Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis.
Germain M, De Arcangelis A, Robinson SD, Baker M, Tavora B, D'Amico G, Silva R, Kostourou V et al.
J Pathol vol. 220 (3), 370-381.  
01-02-2010
Modelling breast cancer in a three-dimensional heterotypic culture system
Holliday DL, Maltby S, Moss MA, Hanby AM, Jones JL, Speirs V
 
01-01-2010
Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
Guttery DS, Hancox RA, Mulligan KT, Hughes S, Lambe SM, Pringle JH, Walker RA, Jones JL et al.
Breast Cancer Res vol. 12 (4) 
01-01-2010
Progression of Ductal Carcinoma in Situ from the Pathological Perspective
Cunha POR, Ornstein M, Jones JL
Breast Care vol. 5 (4), 233-239.  
01-01-2010

2009

A HUMAN HETEROTYPIC BREAST MODEL FOR TRANSLATIONAL STUDIES OF DUCTAL CARCINOMA IN SITU (DCIS) PROGRESSION.
Holliday DL, Brouilette KT, Markert A, Jones JL
 
01-05-2009
Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression
Holliday DL, Brouilette KT, Markert A, Gordon LA, Jones JL
Breast Cancer Res vol. 11 (1) 
01-01-2009
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, Shaw JA, Walker RA et al.
Breast Cancer Res vol. 11 (2) 
01-01-2009
Characterisation of Interleukin-8 and monocyte chemoattractant protein-1 expression within the abdominal aortic aneurysm and their association with mural inflammation.
Middleton RK, Bown MJ, Lloyd GM, Jones JL, London NJ, Sayers RD
Eur J Vasc Endovasc Surg vol. 37 (1), 46-55.  
01-01-2009

2008

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer
Mintz PJ, Habib NA, Jones JL, Giamas G, Lewis JS, Bowen RL, Coombes RC, Stebbing J
Cancer vol. 113 (6), 1489-1495.  
15-09-2008
Reply: Early onset of breast cancer in black British women: how reliable are the findings?
Duffy SW, Bowen RL, Ryan DA, Hart IR, Jones JL
Brit J Cancer vol. 99 (6), 988-988.  
09-09-2008
Reply: Early onset of breast cancer in British black women
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL
British Journal of Cancer vol. 98 (12) 
17-06-2008
Early onset of breast cancer in British black women - Reply
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL
Brit J Cancer vol. 98 (12), 2012-2012.  
10-06-2008
Reply: Early onset breast cancer in black British women: a letter to the editor of British Journal of Cancer regarding early onset of breast cancer in a group of British black women
Bowen R, Duffy S, Ryan D, Hart I, Jones L
Brit J Cancer vol. 98 (8), 1483-1484.  
22-04-2008
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion
Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL et al.
Cancer Res vol. 68 (8), 2755-2763.  
15-04-2008
A review of the S100 proteins in cancer
Salama I, Malone PS, Mihaimeed F, Jones JL
Ejso-Eur J Surg Onc vol. 34 (4), 357-364.  
01-04-2008
The role of radiotherapy in treating small early invasive breast cancer.
Varghese P, Gattuso JM, Mostafa AIH, Abdel-Rahman AT, Shenton KC, Ryan DA, Jones JL, Wells CA et al.
Eur J Surg Oncol vol. 34 (4), 369-376.  
01-04-2008
Early onset of breast cancer in a group of British black women
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL
Brit J Cancer vol. 98 (2), 277-281.  
22-01-2008
De novo expression of alpha(v)beta(6) integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression
Allen M, Mulligan K, Clark S, Hart I, Marshall JF, Jones JL
 
01-01-2008
Predictive markers in breast cancer - the present
Payne SJL, Bowen RL, Jones JL, Wells CA
Histopathology vol. 52 (1), 82-90.  
01-01-2008
Altered myoepithelial cell expression and function in cancer-containing breasts
Modes V, Rodrigues CM, Nyquist N, Shaw JA, Jones JL, Walker RA
 
01-01-2008
The role of cell-cell and cell-stromal interactions in predicting breast cancer behavior
Holliday DL, Jones JL
In Prognostic and Predictive Factors in Breast Cancer 53-67.  
01-01-2008

2007

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and proliferation through MMP-dependant and -independant mechanisms
Alcock RA, Allen MD, Holliday DL, Edwards DR, Pennington CL, Shaw JA, Walker RA, Pringle JH et al.
 
01-12-2007
Expression of alphavbeta6 supersedes Her2 and triple-negative/basal classification of breast cancer and defines novel subgroups with poor survival: implications for breast cancer classification and treatment
Jones JL, Thomas GJ, Duffy SW, Gabe R, Ellis I, Green A, Saha A, Mulligan KT et al.
 
01-12-2007
Molecular profiling of DCIS: identification of distinct subgroups of potential prognostic importance
Clark SE, Marshall JE, Hart IR, Carpenter R, Jones JL
 
01-12-2007
Development of in vitro models to study microenvironmental influences on breast cancer progression
Holliday DL, Mulligan KT, Jones JL
 
01-12-2007
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL
Clin Cancer Res vol. 13 (22 Pt 1), 6673-6680.  
15-11-2007
The use of multiple displacement amplified DNA as a control for methylation specific PCR, pyrosequencing, bisulfite sequencing and methylation-sensitive restriction enzyme PCR.
Hughes S, Jones JL
Bmc Mol Biol vol. 8 
16-10-2007
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion.
Holliday DL, Hughes S, Shaw JA, Walker RA, Jones JL
Breast Cancer Res vol. 9 (5) 
01-01-2007

2006

EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma
Edwards JG, Swinson DEB, Jones JL, Waller DA, O'Byrne KJ
Lung Cancer vol. 54 (3), 399-407.  
01-12-2006
Analysis of MMP single nucleotide polymorphisms in relation to breast cancer progression
Hughes S, Holliday D, Shaw J, Duffy S, Hart I, Jones L
 
01-09-2006
Expression of invasion promoting Tn-C isoforms in DCIS
Lloyd K, Pringle JH, Alcock RA, Jones JL, Walker RA, Shaw JA
 
01-09-2006
A review of the ethnic differences in breast cancer
Bowen RL, Stebbing J, Jones LJ
Pharmacogenomics vol. 7 (6), 935-942.  
01-09-2006
Expression of the tenascin-binding alpha 9 beta 1 integrin in normal breast, DCIS and invasive breast cancer
Nitch-Smith HL, Walker R, Hart IR, Carpenter R, Jones JL
 
01-09-2006
Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WRW, Anderton M, Schwalbe EC, Jones JL, Furness PN, Bell PRF, Thompson MM
Circulation vol. 113 (3), 438-445.  
24-01-2006
Functional analysis of altered Tenascin isoform expression in breast cancer
Alcock RA, Pringle JH, Shaw JA, Holliday DL, Allen M, Walker RA, Jones JL
 
01-01-2006
Functional analysis of normal and DCIS modified breast myoepithelial cells
Allen M, Mulligan K, Clark S, Hart I, Marshall JF, Jones JL
 
01-01-2006
Overdiagnosis and overtreatment of breast cancer - Progression of ductal carcinoma in situ: the pathological perspective
Jones JL
Breast Cancer Res vol. 8 (2) 
01-01-2006

2005

Tenascin-C isoform expression in colorectal cancer
Grierson C, Holliday DL, Jameson JS, Pringle JH, Jones JL
 
01-10-2005
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming
Errington F, Jones J, Merrick A, Bateman A, Harrington K, Gough M, O'Donnell D, Selby P et al.
Gene Therapy, Springer Nature vol. 13 (2), 138-149.  
01-09-2005
Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm
Wilson WRW, Schwalbe EC, Jones JL, Bell PRF, Thompson MM
 
01-07-2005
Phospho-Akt expression is associated with a favorable outcome in non-small cell lung cancer
Shah A, Swain WA, Richardson D, Edwards J, Stewart DJ, Richardson CM, Swinson DEB, Patel D et al.
Clin Cancer Res vol. 11 (8), 2930-2936.  
15-04-2005
Hypoxia and angiogenesis in colorectal liver metastases
Sutton CD, Marshall LJ, Goddard JC, O'Byrne K, Garcia G, Jones JL, Dennison AR, Poston G et al.
 
01-04-2005
Growth regulation is altered in cancer-containing breasts.
Walker RA, Rodrigues CM, Gordon-Weeks A, Luckett JC, Jones JL
 
01-01-2005
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and proliferation.
Alcock RA, Holliday DL, Shaw JA, Walker RA, Pringle JH, Jones JL
 
01-01-2005
The tumour-suppressor function of breast myoepithelial cells is mediated in part through regulation of S100A9.
Mulligan KT, Wang H, Shaw JA, Hart IR, Jones JL
 
01-01-2005

2004

Stromal contribution to breast cancer cell invasion: Intrinsic genetic differences relate to invasion promoting ability
Holliday DL, Shaw JA, Walker RA, Jones JL
 
01-09-2004
Signal transduction and cell cycle regulation by the breast myoepithelial cells
Luckett JCA, Shaw JA, Jones JL, Walker RA
 
01-09-2004
Analysis of the functional significance of altered Tenascin isoform expression in breast cancer
Alcock RA, Adams M, Pringle JH, Shaw JA, Walker RA, Jones JL
 
01-09-2004
Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
Swinson DEB, Jones JL, Cox G, Richardson D, Harris AL, O'Byrne KJ
Int J Cancer vol. 111 (1), 43-50.  
10-08-2004
Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity.
Molloy KJ, Thompson MM, Jones JL, Schwalbe EC, Bell PRF, Naylor AR, Loftus IM
Circulation vol. 110 (3), 337-343.  
20-07-2004
Favourable outcome for patients with myeloid disorders treated with fludarabine–melphalan reduced‐intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T‐lymphocyte‐depleting antibodies
Malladi RK, Peniket AJ, Norton AE, Campbell AJ, Collins GP, Samol J, Eagleton H, Miller E et al.
European Journal of Haematology, Wiley vol. 73 (2), 85-92.  
09-07-2004
Biological factors influencing angiogenesis and prognosis in resected colorectal liver metastases
Sutton CD, Marshall LJ, Goddard JC, O'Byrne K, Garcia G, Jones JL, Dennison AR, Poston G et al.
 
01-05-2004
Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma
Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, Girling AC, Ball RY, Edwards DR
Clin Cancer Res vol. 10 (7), 2429-2440.  
01-04-2004

2003

Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL, Shaw JA, Pringle JH, Walker RA
J Pathol vol. 201 (4), 562-572.  
01-12-2003
Differential expression of metallothionein 1 and 2 lsoforms in breast cancer lines with different invasive potential - Identification of a novel nonsilent metallothionein-1H mutant variant
Tai SK, Tan OJK, Chow VTK, Jin RX, Jones JL, Tan PH, Jayasurya A, Bay BH
Am J Pathol vol. 163 (5), 2009-2019.  
01-11-2003
Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma
Edwards JG, Swinson DEB, Jones JL, Muller S, Waller DA, O'Byrne KJ
Chest vol. 124 (5), 1916-1923.  
01-11-2003
Genetic alterations in epithelial and stromal cells of breast cancers and surrounds
Al Bahlani S, Shaw JA, Whyman G, Potter L, Walker RA, Jones JL
 
01-09-2003
Expression of tenascin AD1 domain in breast is not specific to malignancy
Alcock RA, Shaw JA, Pringle JH, Walker RA, Jones JL
 
01-09-2003
Breast cell invasive potential relates to the myoepithelial phenotype.
Gordon LA, Mulligan KT, Maxwell-Jones H, Adams M, Walker RA, Jones JL
Int J Cancer vol. 106 (1), 8-16.  
10-08-2003
Carbonic anhydrase ix independently predicts survival in colorectal liver metastases
Marshall LJ, Sutton CD, Jones JL, O'Byrne K, Dennison AR, Poston G, Lloyd DM, Berry DP
 
01-06-2003
Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
Edwards JG, McLaren J, Jones JL, Waller DA, O'Byrne KJ
Brit J Cancer vol. 88 (10), 1553-1559.  
19-05-2003
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.
Chauhan H, Abraham A, Phillips JRA, Pringle JH, Walker RA, Jones JL
J Clin Pathol vol. 56 (4), 271-276.  
01-04-2003
Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M et al.
Biochem Pharmacol vol. 65 (3), 361-376.  
01-02-2003
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DEB, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL et al.
J Clin Oncol vol. 21 (3), 473-482.  
01-02-2003

2002

Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
Shaw JA, Udokang K, Mosquera J-M, Chauhan H, Jones JL, Walker RA
J Pathol vol. 198 (4), 450-457.  
01-12-2002
Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer.
Goddard JC, Sutton CD, Jones JL, O'Byrne KJ, Kockelbergh RC
Eur Urol vol. 42 (5), 464-468.  
01-11-2002
Expression of the cell adhesion molecule p120 differs between infiltrating ductal and infiltrating lobular carcinomas
Dhillon J, Pavlou G, Jones JL, Walker RA
J Pathol vol. 198, 30A-30A.  
01-09-2002
Analysis of the tumour suppressor role of breast myoepithelial cells
Mulligan KT, Shaw JA, Gordon LA, Holliday DL, Luckett JA, Walker RA, Jones JL
J Pathol vol. 198, 3A-3A.  
01-09-2002
Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables.
Swinson DEB, Jones JL, Richardson D, Cox G, Edwards JG, O'Byrne KJ
Lung Cancer vol. 37 (3), 235-240.  
01-09-2002
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in-situ and invasive breast lesions
Abrahams A, Chauhan H, Phillips J, Pringle JH, Walker RA, Jones JL
J Pathol vol. 198, 31A-31A.  
01-09-2002
Expression of matrilysin (MMP-7) protein in benign and malignant breast
Bamford WM, Saleem M, Kulbicki K, Walker RA, Jones JL
J Pathol vol. 198, 31A-31A.  
01-09-2002
Tumour necrosis correlates with angiogenesis and is a prognostic factor in malignant mesothelioma
Edwards JG, Swinson D, Jones JL, Cox G, O'Byrne KJ
Brit J Cancer vol. 86, S97-S97.  
01-06-2002
Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M, Jones JL, Walker RA, Pringle JH, Bell SC
Cancer Res vol. 62 (11), 3289-3297.  
01-06-2002
beta-catenin in non-small cell lung cancer (NSCLC)
Swinson DEB, Lolljee J, Edwards JG, Jones JL, Cox G, Richardson D, O'Byrne KJ
Brit J Cancer vol. 86, S59-S60.  
01-06-2002
Hypoxia inducible factor (HIF)-1 alpha in non-small cell lung cancer (NSCLC)
Swinson DEB, Jones JL, Cox G, Richardson C, Richardson D, Allen C, O'Byrne KJ
Brit J Cancer vol. 86, S28-S28.  
01-06-2002

2001

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer
Cox G, Jones JL, Andi A, Abrams KR, O'Byrne KJ
Lung Cancer-J Iaslc vol. 34 (3), 417-426.  
01-12-2001
Towards a biological staging model for operable non-small cell lung cancer
O'Byrne KJ, Cox G, Swinson D, Richardson D, Edwards JG, Lolljee J, Andi A, Koukourakis MI et al.
 
01-12-2001
Angiogenesis is an independent prognostic factor in malignant mesothelioma
Edwards JG, Cox G, Andi A, Jones JL, Walker RA, Waller DA, O'Byrne KJ
Brit J Cancer vol. 85 (6), 863-868.  
14-09-2001
Effect of matrilysin (MMP-7) on breast cancer cell behaviour
Saleem M, Gordon LA, Adams M, Walker RA, Jones JL
J Pathol vol. 195, 7A-7A.  
01-09-2001
Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin
Banerjee AR, Jones JL, Birchall JP, Powe DG
Otol Neurotol vol. 22 (5), 579-581.  
01-09-2001
Desmosomal adhesion regulates epithelial morphogenesis and cell positioning
Runswick SK, O'Hare MJ, Jones L, Streuli CH, Garrod DR
Nat Cell Biol vol. 3 (9), 823-830.  
01-09-2001
Characterisation of stromal changes in invasive and pre-invasive breast disease
Phillips JRA, Adams M, Gordon LA, Walker RA, Jones JL
J Pathol vol. 195, 28A-28A.  
01-09-2001
Expression of P- and N-cadherin in breast carcinomas.
Kovacs A, Dhillon J, Jones JL, Walker RA
J Pathol vol. 195, 27A-27A.  
01-09-2001
A biological staging model for operable non-small cell lung cancer.
Cox G, Jones JL, Andi A, Waller DA, O'Byrne KJ
Thorax vol. 56 (7), 561-566.  
01-07-2001
Reduction in immunohistochemical staining of thrombospondin-1 predicts progression in superficial bladder cancer
Goddard JC, Sutton CD, Jones JL, O'Byrne KJ, Kockelbergh RC
Brit J Cancer vol. 85, 35-35.  
01-07-2001
Reduction in thrombospondin 1 expression significantly correlates with disease progression in superficial bladder cancer
Goddard JC, Sutton CD, Jones JL, Berry DP, O'Byrne KJ, Kockelbergh RC
Brit J Surg vol. 88, 8-8.  
01-05-2001

2000

Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall
Crowther M, Goodall S, Jones JL, Bell PRF, Thompson MM
British Journal of Surgery, Oxford University Press (Oup) vol. 87 (10), 1391-1400.  
01-10-2000
Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms
Crowther M, Goodall S, Jones JL, Bell PRF, Thompson MM
Journal of Vascular Surgery, Elsevier vol. 32 (3), 575-583.  
01-09-2000
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Cox G, Jones JL, O'Byrne KJ
Clinical Cancer Research vol. 6 (6), 2349-2355.  
01-06-2000
Angiogenesis and non-small cell lung cancer
Cox G, Jones JL, Walker RA, Steward WP, O’Byrne KJ
Lung Cancer, Elsevier vol. 27 (2), 81-100.  
01-02-2000
Prognostic indices in breast carcinoma
Walker RA, Jones JL
Cpd Bulletin Cellular Pathology vol. 2 (2), 85-88.  
01-01-2000

1999

MMP-9 and the epidermal growth factor signal pathway in non-small cell lung cancer
Cox G, Jones JL, O'Byrne KJ
Thorax vol. 54 (SUPPL. 3) 
01-12-1999
Expression and prognostic influence of MMP-2, MMP-9 and TIMP-2 in non-small cell lung cancer
Cox G, Jones JL, O'Byrne KJ
Thorax vol. 54 (SUPPL. 3) 
01-12-1999
Expression of MMP‐2 and MMP‐9, their inhibitors, and the activator MT1‐MMP in primary breast carcinomas
Jones JL, Glynn P, Walker RA
The Journal of Pathology, Wiley vol. 189 (2), 161-168.  
01-10-1999
Integrins: a role as cell signalling molecules.
Jones JL, Walker RA
Molecular Pathology, Bmj vol. 52 (4) 
01-08-1999

1998

Erratum: Clinical otolaryngology and allied sciences (Clinical Otolaryngology (1998) 23 (273-278))
Banerjee AR, Powe D, Jones JL
Clinical Otolaryngology and Allied Sciences vol. 23 (6) 
01-12-1998
An immunocytochemical study of Matrixmetalloproteinase 1 in cholesteatoma and deep meatal skin
Banerjee, Powe, Jones
 
01-06-1998

1997

Control of matrix metalloproteinase activity in cancer
Jones JL, Walker RA
The Journal of Pathology, Wiley vol. 183 (4), 377-379.  
01-12-1997
Cell-cell and cell-stromal interactions in breast cancer invasion and metastasis (review).
Jones J, Walker R
International Journal of Oncology, Spandidos Publications vol. 11 (3), 609-616.  
01-09-1997
Modulation of Myoepithelial-Associated α6β4 Integrin in a Breast Cancer Cell Line Alters Invasive Potential
Jones JL, Royall JE, Critchley DR, Walker RA
Experimental Cell Research, Elsevier vol. 235 (2), 325-333.  
01-09-1997
Molecular pathology of breast cancer and its application to clinical management
Walker RA, Jones JL, Chappell S, Walsh T, Shaw JA
Cancer and Metastasis Reviews, Springer Nature vol. 16 (1-2), 5-27.  
01-06-1997

1996

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
Jones J, Royall J, Walker R
British Journal of Cancer, Springer Nature vol. 74 (8), 1237-1241.  
01-10-1996
An immunohistochemical study of the dermal infiltrate and epidermal staining for interleukin 1 in 12 cases of Sweet's syndrome
BOURKE JF, JONES JL, GRAHAM-BROWN RAC
British Journal of Dermatology, Oxford University Press (Oup) vol. 134 (4), 705-709.  
01-04-1996

1994

Assessment of epidermal dendritic cell markers and T‐lymphocytes in psoriasis
Jones JL, Berth‐Jones J, Fletcher A, Hutchinson PE
The Journal of Pathology, Wiley vol. 174 (2), 77-82.  
01-10-1994

1992

Alteration of stromal protein and integrin expression in breast—a marker of premalignant change?
Jones JL, Critchley DR, Walker RA
The Journal of Pathology, Wiley vol. 167 (4), 399-406.  
01-08-1992
Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts
Walker RA, Cowl J, Dhadly PP, Jones JL
The Breast, Elsevier vol. 1 (2), 87-91.  
01-06-1992

1991

In vitro modulation of cellular localization of milk fat globule membrane antigens in human breast carcinomas
Corcoran D, Jones JL, Walker RA
The Journal of Pathology, Wiley vol. 164 (2), 127-133.  
01-06-1991

1989

An immunohistochemical and in situ hybridization study of c‐myc and c‐erbB‐2 expression in primary human breast carcinomas
Walker RA, Senior PV, Jones JL, Critchley DR, Varley JM
The Journal of Pathology, Wiley vol. 158 (2), 97-105.  
01-06-1989

1987

The assessment of in vitro modulation of milk fat globule membrane expression by human breast carcinomas
Jones JL, Walker RA
The Journal of Pathology, Wiley vol. 153 (1), 51-60.  
01-09-1987

1986

Haemorrhagic, traumatic tenosynovitis
Dacruz DJ, Harris AM, Jones J
Journal of Hand Surgery (European Volume), Sage Publications vol. 11 (2), 223-224.  
01-06-1986

Coenzyme A homeostasis regulates hypoxic signalling via UBFD1 in triple-negative breast cancer
Grevitt P, Maiques O, Shah KM, Morales V, Gadaleta E, Dodel M, Bianchi K, Gout I et al.
In Biorxiv